Connable Office Inc’s ICU Medical ICUI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$279K Buy
1,903
+160
+9% +$20.9K 0.02% 193
2026
Q1
$225K Hold
1,743
0.02% 207
2025
Q4
$249K Hold
1,743
0.02% 210
2025
Q3
$209K Hold
1,743
0.02% 212
2025
Q2
$230K Sell
1,743
-111
-6% -$15K 0.02% 206
2025
Q1
$257K Sell
1,854
-102
-5% -$15.8K 0.03% 187
2024
Q4
$304K Sell
1,956
-75
-4% -$12.7K 0.03% 188
2024
Q3
$370K Buy
2,031
+122
+6% +$18.1K 0.04% 170
2024
Q2
$227K Hold
1,909
0.02% 199
2024
Q1
$205K Buy
+1,909
New +$190K 0.02% 203

Other funds holding ICUI

Connable Office Inc's ICUI Position: Q2 2026 in Review

Connable Office Inc increased its ICU Medical (ICUI) stake by 9.2% in Q2 2026, buying an estimated $20.9K and bringing the position to 1,903 shares worth $279K. The position accounts for 0.02% of the portfolio, ranked #193.

Connable Office Inc first reported a position in ICUI in Q1 2024 and has held it in 10 quarters since. The position peaked at $370K in Q3 2024. 289 funds tracked by Wall St. Rank hold ICUI as of Q2 2026.

  • Connable Office Inc held 1,903 shares of ICU Medical worth $279K as of Q2 2026.
  • Connable Office Inc bought 160 ICU Medical shares in Q2 2026, an estimated $20.9K.
  • ICU Medical made up 0.02% of Connable Office Inc's portfolio in Q2 2026, its #193 holding.
  • Connable Office Inc first reported a position in ICU Medical in Q1 2024 and has held it in 10 quarters since.
  • Connable Office Inc's ICU Medical position peaked at $370K in Q3 2024.
  • 289 funds tracked by Wall St. Rank held ICU Medical as of Q2 2026.

Based on Connable Office Inc's 13F filing for Q2 2026, filed 3 Aug 2026.